Evidence map›Paper›PMID 36791317›Full record

ArticleHealth security

A Path Forward: COVID-19 Vaccine Equity Community Education and Outreach Initiative.

Risha Irvin, Maya Venkataramani, Panagis Galiatsatos, Jeanne D Hitchcock, Nondie Hemphill, Margaret Dearey, Benjamin F Bigelow, Lisa A Cooper, Nancy Edwards Molello, Katie J O'Conor and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Health security. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Risha IrvinRisha Irvin, MD, MPH, is Associate Vice Chair for Diversity, Equity, and Inclusion, Department of Medicine; and Associate Professor, Division of Infectious Diseases; Johns Hopkins University School of Medicine, Baltimore, MD.
Maya VenkataramaniMaya Venkataramani, MD, MPH, is an Assistant Professor, Division of General Internal Medicine of Medicine and Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD.
Panagis GaliatsatosPanagis Galiatsatos, MD, MHS, is Co-Director, Medicine for the Greater Good, and an Assistant Professor, Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Jeanne D HitchcockJeanne D. Hitchcock, JD, is Special Advisor to the Vice President for Local Government, Community, and Corporate Affairs; Johns Hopkins Local Government and Community Affairs, Johns Hopkins University and Medicine, Baltimore, MD.
Nondie HemphillNondie Hemphill, JD, is Associate Director, Johns Hopkins Local Government and Community Affairs, Johns Hopkins University and Medicine, Baltimore, MD.
Margaret DeareyMargaret Dearey, MHS, is a Research Program Coordinator, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD.
Benjamin F BigelowBenjamin F. Bigelow is Director, COVID-19 Mobile Vaccine Team, Johns Hopkins Health System, Baltimore, MD.
Lisa A CooperLisa A. Cooper, MD, MPH, is a Bloomberg Distinguished Professor, Equity in Health and Healthcare, Department of Health, Behavior, and Society; Director, Johns Hopkins Center for Health Equity; and Director, Johns Hopkins Urban Health Institute; all at the Johns Hopkins Bloomberg School of Public Health. She is also the James F. Fries Professor of Medicine, Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Nancy Edwards MolelloNancy Edwards Molello, MSB, is Program Director, Operations and Strategic Initiatives, Johns Hopkins Center for Health Equity, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Katie J O'ConorKatie J O'Conor, MD, is Faculty and Chief Diversity Officer, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Kathleen R PageKathleen R. Page, MD, is an Associate Professor, Division of Infectious Diseases, and Co-Director, Center for Salud/Health and Opportunities for Latinos, Johns Hopkins University School of Medicine, Baltimore, MD.
Sherita H GoldenSherita H. Golden, MD, MHS, is Vice President and Chief Diversity Officer, Johns Hopkins Medicine; and Hugh P. McCormick Family Professor of Endocrinology and Metabolism, Johns Hopkins Division of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD.

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
The Impact of HCV Treatment in HIV/HCV coinfected and HCV monoinfected Incarcerated Persons on HCV EliminationR01DA013806 · NIDA · JOHNS HOPKINS UNIVERSITY · PI IRVIN, RISHA, THOMAS, DAVID L · 2000 to 2024
$8.7M
Juntos (Together): A community led approach to enhance to Covid-19 testing among vulnerable LatinosR01DA045556 · NIDA · JOHNS HOPKINS UNIVERSITY · PI LUCAS, GREGORY M, PAGE, KATHLEEN R · 2017 to 2022
$6.8M
Mentoring in Community-engaged Research to Promote Outcomes for LatinosK24NR020508 · NINR · JOHNS HOPKINS UNIVERSITY · PI Kathleen R Page · 2022 to 2026
$942k
NIAID NIH HHS P30 AI094189NIDA NIH HHS R01 DA013806NIDA NIH HHS R01 DA045556
6 · The paper itself

Abstract

COVID-19 vaccines offer hope to end the COVID-19 pandemic. In this article, we document key lessons learned as we continue to confront COVID-19 variants and work to adapt our vaccine outreach strategies to best serve our community. In the fall of 2020, the Office of Diversity, Inclusion and Health Equity at Johns Hopkins Medicine, in collaboration with the Office of Government and Community Affairs for Johns Hopkins University and Medicine, established the COVID-19 Vaccine Equity Community Education and Outreach Initiative in partnership with faith and community leaders, local and state government representatives, and community-based organizations. Working with community and government partnerships established before COVID-19 enabled our team to quickly build infrastructure focused on COVID-19 vaccine education and equity. These partnerships resulted in the development and implementation of web-based educational content, major culturally adapted media campaigns (reaching more than 200,000 individuals), community and faith education outreach, youth-focused initiatives, and equity-focused mobile vaccine clinics. The community mobile vaccine clinics vaccinated over 3,000 people in the first 3 months. Of these, 90% identified as persons of color who have been disproportionately impacted during the COVID-19 pandemic. Academic-government-community partnerships are vital to ensure health equity. Community partnerships, education events, and open dialogues were conducted between the community and medical faculty. Using nontraditional multicultural media venues enabled us to reach many community members and facilitated informed decisionmaking. Additionally, an equitable COVID-19 vaccine policy requires attention to vaccine access as well as access to sound educational information. Our initiative has been thoughtful about using various types of vaccination sites, mobile vaccine units, and flexible hours of operation.

Indexed as

COVID-19COVID-19 VaccinesAdolescentHumansPandemicsSARS-CoV-2COVID-19 VaccinesCommunity educationCommunity partnershipsCOVID-19Epidemic management/responseHealth equityRisk communicationVaccines

Identifiers

PMID36791317
PMCPMC10079247

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.